InVera Medical - Galway

Venari Medical has a vision to revolutionize the treatment of vascular diseases and improve the quality of life of patients. The company is developing BioVena™, a more efficient and faster procedure to treat all venous diseases. This technology has the potential to disrupt the current treatment methods, which have seen minimal improvement in the past decade. The team is based at Galway's medtech hub in Ireland. Unfortunately, only 1.3 million out of the 120 million people in the US and EU who suffer from venous diseases are currently receiving endovenous treatment. What's more, 3 million venous ulcer patients are receiving no treatment at all and are stuck using ineffective compression bandaging. Venari Medical's revolutionary, lower-risk, and highly effective non-thermal treatment will  

Show more

make it easier and more accessible for those suffering from venous diseases to receive proper treatment. The indication for superficial venous ablation is also set to expand to treat venous ulcers, which cost insurers in the US and EU $33 billion annually. With this new technology, more patients will be able to access safe and effective treatments that were not available before.